BioScience Managers
  • About Us
  • Team
    • Senior Team
    • Board of Directors
    • Industry Expert Advisors
  • Portfolio
  • Funds & Strategy
    • Asia Pacific Healthcare Fund II
    • BioScience Managers Translation Fund I
    • BioScience Managers Ventures Fund I
    • Downing FOUR Healthcare Share Class
  • News & Media
  • Contact Us
  • Menu Menu
  • LinkedIn

Bioxyne Ltd – Sale of HI-164OV Hunter Immunology Pty Ltd

2nd December 2013/in Portfolio Companies

Please find the ASX announcement here.

Bioxyne divests its COPD related HI-164OV research program for up to $1.56 million.

Share this entry
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
/wp-content/uploads/2018/01/BSM_logo.png 0 0 keymaster /wp-content/uploads/2018/01/BSM_logo.png keymaster2013-12-02 17:50:282018-01-06 17:50:49Bioxyne Ltd – Sale of HI-164OV Hunter Immunology Pty Ltd
  • BioScience Managers Pty Ltd – legal
  • BioScience Managers UK Ltd – legal
© BioSciences Managers, all rights reserved

Website by Instinctif Partners

Avita Medical – Results of Annual General Meeting Bioxyne Ltd CEO Steps Down
Scroll to top